2016

  • ‘Fertility preservation in children with cancer: quality of clinical practice guidelines and variations in recommendations’, Amsterdam Kindersymposium, 18 Feb 2016, Anna Font-Gonzalez (AMC)
  • ‘Auditory complications after childhood cancer in Switzerland’, Swiss Peadiatric Oncology Group (SPOG) Symposium, 03 June 2016, Bern, Dr. Annette Weiss (UNIBE)

2015

  • ‘Swiss participation in a European late effects study: PanCareLIFE’, Swiss Paediatric Oncology Group Conference, 17 Jan 2015, Dr. Rahel Kuonen (UNIBE)
  • ‘Ototoxicity after cancer in childhood and adolescence in Switzerland’, Swiss Paediatric Oncology Group Conference, 17 Jan 2015, Dr. Annette Weiss (UNIBE)
  • ‘Progressive post-treatment unilateral/asymmetrical threshold changes following cranial radiation in combination with platin-based chemotherapy’ Deutsche Gesellschaft für Audiologie (German Society of Audiology), Bochum, Germany, 4-7 March 2015, Dr. R. Parfitt (UKM)
  • ‘Verbesserung der Versorgung von Krebspatienten: Planung klinisch-epidemiologischer Studien anhand von Daten aus dem Deutschen Kinderkrebsregister’ Quality of cancer care (QoCC) – Interdisziplinärer Kongress, Berlin, 26-27 March 2015, Dr. P. Kaatsch (UMC-Mainz), Dr. M. Blettner (UMC-Mainz)
  • “Early Detection of Fertility Impairment after Childhood and Adolescent Cancer”, Brno Oncology Days, Brno, Czech Republic, 8 – 10 April 2015, Dr. T. Kepak (UHB)
  • ‘Outcome after childhood cancer – Research of late effects to improve cure and care’, 3rd Scientific Retreat – German Cancer Consortium (DKTK), Heidelberg, Germany 13-14 April 2015, Dr. C. Spix (UMC-Mainz), Dr. P. Kaatsch (UMC-Mainz), Dr. D. Grabow (UMC-Mainz), Dr. M. Blettner (UMC-Mainz)
  • ‘Ototoxicity in Swiss childhood cancer long-term survivors’, Swiss Public Health Conferencein Geneva, 17-18 September 2015, Dr. Annette Weiss (UNIBE)
  • ‘Fertility preservation in children with cancer: quality of clinical practice guidelines and variations in recommendations’, International Society of Pediatric Oncology (SIOP) conference, 8-11 October 2015, Anna Font Gonzalez (AMC)
  • ‘Fertility preservation in children with cancer: quality of clinical practice guidelines and variations in recommendations’, Amsterdam Kindersymposium, 19 Feb 2016, Anna Font Gonzalez (AMC)
  • ‘The influence of co-medication on platinum-related ototoxocity in long-term survivors of childhood cancer: an observational DCOG study’, International Society of Pediatric Oncology (SIOP) conference, 8-11 October 2015, Eva Clemens (EMC)

2014

  • FNM Motol Hospital, 21 Jan 2014, Dr. Jarmila Kruseova (FNM)
  • Swiss Paediatric Oncology Group, 01 Feb 2014, Prof. Claudia Kuehni (UNIBE)
  • 13th PanCare Meeting (Wroclaw, Poland), 12-14 May 2014
  • ‘Wenn Kinder erwachsen werden – Spätfolgen der Krebstherapie. Faszination Forschung: Leben nach dem Krebs’, Medizinische Gesellschaft Mainz – Akademie für ärztliche Fortbildung Rheinland-Pfalz. Mainz, Germany, 21 May 2014, Dr. P. Kaatsch (UMC-Mainz)
  • ‘EU-Antragstellung: ein Erfahrungsbericht zu PanCare Netzwerk, PanCareSurFup, PanCareLIFE und Neues am Horizon(t) 2020. „10 years after – Experience in Clinical Research Mainz“’, University Medical Centre Mainz, 23 May 2014, Dr. D. Grabow (UMC-Mainz)
  • Childhood Cancer Survivor Cohorts in Europe’ (abstract nr. 99), 12th Acta Oncologica Symposium, 08 – 09 Sept 2014, Dr. Jeanette Falck Winther (KB)
  • ‘A European project on late effects after childhood and adolescent cancer’, European Symposium of late Complications after Childhood Cancer (ESLCCC), Edinburgh, 15-16 September 2014, Dr. Peter (UMC-Mainz), Dr. J. Byrne (BOYNE)
  • ‘Early detection of children at risk to develop significant platinum-induced hearing loss – pharmacogenetic screening options’, XXVII. Congress of the Union of the European Phoniatricians, Moscow, Russian Federation, 02 – 05 October 2014, Prof. Dr. med. am Zehnhoff-Dinnesen (UKM)
  • 14th PanCare Meeting (Lucerne, Switzerland), 8-10 October 2014, Dr. P. Kaatsch, Dr. Julianne Byrne (BOYNE), Dr. J. Kruseová (FNM)
  • ‘PanCareLIFE project – Research on hearing disorders and fertility cure pediatric patients’ (Late effects of cancer treatment – round table), XXIV Konference dĕtských hematologü a onkologü České a Slovenské republiky (Czech/Slovak Paediatric Oncology Conference), 10 Oct 2014, Dr. Kepák (UHB)
  • ‘Auditory Late Effects of Childhood Cancer Therapy with Platinum Drugs: Predisposition, Toxicogenetics, and Prevention – Genetic predisposition to late complications after cancer treatment?’ 25th Conference of the Czech and Slovak Paediatric Haematology/Oncology Working Group, 11 Oct 2014, Olomouc, Czech Republic, Prof. Dr. med. Oliver Zolk (University of Ulm/UzL)
  • ‘Die Rolle des Deutschen Kinderkrebsregisters bei der Langzeitnachbeobachtung in der pädiatrischen Onkologie und Hämatologie und das Europäische PanCare-Netzwerk’ HitLife Netzwerk-Tagung. Hamburg, 28 November 2014, Dr. D. Grabow (UMC-Mainz)
  • ‘Special aspects of ototoxicity in children and adolescents with brain tumours’ 1st workshop of HIT-Life, Hamburg, 28-29 Nov 2014, UKM/UzL
  • ‘Ototoxicity after platinium treatment’, Ear Nose and Throat (ENT) conference, Mikulov, Czech republic, 4 – 5 Dec 2014, Dr. J. Kruseová (FNM)

2013

  • Translational Sarcoma Research Meeting, Oct 2013, Prof. Uta Dirksen (UKM)
  • Long Term Follow-Up Committee of the French Society of Childhood Cancer, 12 Nov 2013, Dr. Claire Berger (CHU-SE)
  • ‚Das EU-Projekt PanCareLIFE: Studien zu Fertilität und Ototoxizität mit dem Ziel einer verbesserten gesundheitsbezogenen Lebensqualität nach Krebserkrankung bei Kindern, Jugendlichen und jungen Erwachsenen’, 82. Wissenschaftlichen Halbjahrestagung der Gesellschaft für Pädiatrische Onkologie und Hämatologie e. V. (GPOH). Frankfurt, 22 –23 November 2013, Dr. P. Kaatsch (UMC-Mainz), Prof. T. Langer (UzL), Prof. G. Calaminus (UKM), Dr. D. Grabow (UMC-Mainz), Dr. J. Byrne (BOYNE) for the PanCareLIFE Consortium (Abstract published in: Monatsschr Kinderheilkd 161, 1071, 2013)
  • European Ewing Consortium Meeting, Dec 2013, Prof. Uta Dirksen (UKM)